img

Global Amlodipine Besylate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Amlodipine Besylate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment ofHypertension and Coronary Artery Disease.
Amlodipine Besylate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amlodipine Besylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from High Blood Pressure and Heart Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amlodipine Besylate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Amlodipine Besylate key manufacturers include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. Pfizer, Mylan, Dr. Reddy's Laboratories are top 3 players and held % sales share in total in 2022.
Amlodipine Besylate can be divided into 2.5mg Tablets, 5mg Tablets and 10mg Tablets,, etc. 2.5mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Amlodipine Besylate is widely used in various fields, such as High Blood Pressure and Heart Disease, etc. High Blood Pressure provides greatest supports to the Amlodipine Besylate industry development. In 2022, global % sales of Amlodipine Besylate went into High Blood Pressure filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amlodipine Besylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets

Segment by Application


High Blood Pressure
Heart Disease

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amlodipine Besylate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amlodipine Besylate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amlodipine Besylate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amlodipine Besylate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amlodipine Besylate introduction, etc. Amlodipine Besylate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Amlodipine Besylate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Amlodipine Besylate Market Overview
1.1 Amlodipine Besylate Product Overview
1.2 Amlodipine Besylate Market Segment by Type
1.2.1 2.5mg Tablets
1.2.2 5mg Tablets
1.2.3 10mg Tablets
1.3 Global Amlodipine Besylate Market Size by Type
1.3.1 Global Amlodipine Besylate Market Size Overview by Type (2018-2029)
1.3.2 Global Amlodipine Besylate Historic Market Size Review by Type (2018-2024)
1.3.3 Global Amlodipine Besylate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Amlodipine Besylate Sales Breakdown by Type (2018-2024)
1.4.2 Europe Amlodipine Besylate Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Amlodipine Besylate Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Amlodipine Besylate Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Amlodipine Besylate Sales Breakdown by Type (2018-2024)
2 Global Amlodipine Besylate Market Competition by Company
2.1 Global Top Players by Amlodipine Besylate Sales (2018-2024)
2.2 Global Top Players by Amlodipine Besylate Revenue (2018-2024)
2.3 Global Top Players by Amlodipine Besylate Price (2018-2024)
2.4 Global Top Manufacturers Amlodipine Besylate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Amlodipine Besylate Market Competitive Situation and Trends
2.5.1 Amlodipine Besylate Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Amlodipine Besylate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2022)
2.7 Date of Key Manufacturers Enter into Amlodipine Besylate Market
2.8 Key Manufacturers Amlodipine Besylate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Amlodipine Besylate Status and Outlook by Region
3.1 Global Amlodipine Besylate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Amlodipine Besylate Historic Market Size by Region
3.2.1 Global Amlodipine Besylate Sales in Volume by Region (2018-2024)
3.2.2 Global Amlodipine Besylate Sales in Value by Region (2018-2024)
3.2.3 Global Amlodipine Besylate Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Amlodipine Besylate Forecasted Market Size by Region
3.3.1 Global Amlodipine Besylate Sales in Volume by Region (2024-2029)
3.3.2 Global Amlodipine Besylate Sales in Value by Region (2024-2029)
3.3.3 Global Amlodipine Besylate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Amlodipine Besylate by Application
4.1 Amlodipine Besylate Market Segment by Application
4.1.1 High Blood Pressure
4.1.2 Heart Disease
4.2 Global Amlodipine Besylate Market Size by Application
4.2.1 Global Amlodipine Besylate Market Size Overview by Application (2018-2029)
4.2.2 Global Amlodipine Besylate Historic Market Size Review by Application (2018-2024)
4.2.3 Global Amlodipine Besylate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Amlodipine Besylate Sales Breakdown by Application (2018-2024)
4.3.2 Europe Amlodipine Besylate Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Amlodipine Besylate Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Amlodipine Besylate Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Amlodipine Besylate Sales Breakdown by Application (2018-2024)
5 North America Amlodipine Besylate by Country
5.1 North America Amlodipine Besylate Historic Market Size by Country
5.1.1 North America Amlodipine Besylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Amlodipine Besylate Sales in Volume by Country (2018-2024)
5.1.3 North America Amlodipine Besylate Sales in Value by Country (2018-2024)
5.2 North America Amlodipine Besylate Forecasted Market Size by Country
5.2.1 North America Amlodipine Besylate Sales in Volume by Country (2024-2029)
5.2.2 North America Amlodipine Besylate Sales in Value by Country (2024-2029)
6 Europe Amlodipine Besylate by Country
6.1 Europe Amlodipine Besylate Historic Market Size by Country
6.1.1 Europe Amlodipine Besylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Amlodipine Besylate Sales in Volume by Country (2018-2024)
6.1.3 Europe Amlodipine Besylate Sales in Value by Country (2018-2024)
6.2 Europe Amlodipine Besylate Forecasted Market Size by Country
6.2.1 Europe Amlodipine Besylate Sales in Volume by Country (2024-2029)
6.2.2 Europe Amlodipine Besylate Sales in Value by Country (2024-2029)
7 Asia-Pacific Amlodipine Besylate by Region
7.1 Asia-Pacific Amlodipine Besylate Historic Market Size by Region
7.1.1 Asia-Pacific Amlodipine Besylate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Amlodipine Besylate Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Amlodipine Besylate Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Amlodipine Besylate Forecasted Market Size by Region
7.2.1 Asia-Pacific Amlodipine Besylate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Amlodipine Besylate Sales in Value by Region (2024-2029)
8 Latin America Amlodipine Besylate by Country
8.1 Latin America Amlodipine Besylate Historic Market Size by Country
8.1.1 Latin America Amlodipine Besylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Amlodipine Besylate Sales in Volume by Country (2018-2024)
8.1.3 Latin America Amlodipine Besylate Sales in Value by Country (2018-2024)
8.2 Latin America Amlodipine Besylate Forecasted Market Size by Country
8.2.1 Latin America Amlodipine Besylate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Amlodipine Besylate Sales in Value by Country (2024-2029)
9 Middle East and Africa Amlodipine Besylate by Country
9.1 Middle East and Africa Amlodipine Besylate Historic Market Size by Country
9.1.1 Middle East and Africa Amlodipine Besylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Amlodipine Besylate Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Amlodipine Besylate Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Amlodipine Besylate Forecasted Market Size by Country
9.2.1 Middle East and Africa Amlodipine Besylate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Amlodipine Besylate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Amlodipine Besylate Products Offered
10.1.5 Pfizer Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Mylan Amlodipine Besylate Products Offered
10.2.5 Mylan Recent Development
10.3 Dr. Reddy's Laboratories
10.3.1 Dr. Reddy's Laboratories Company Information
10.3.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Products Offered
10.3.5 Dr. Reddy's Laboratories Recent Development
10.4 Apotex
10.4.1 Apotex Company Information
10.4.2 Apotex Introduction and Business Overview
10.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Apotex Amlodipine Besylate Products Offered
10.4.5 Apotex Recent Development
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Company Information
10.5.2 Teva Pharmaceutical Introduction and Business Overview
10.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Teva Pharmaceutical Amlodipine Besylate Products Offered
10.5.5 Teva Pharmaceutical Recent Development
10.6 Cipla
10.6.1 Cipla Company Information
10.6.2 Cipla Introduction and Business Overview
10.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Amlodipine Besylate Products Offered
10.6.5 Cipla Recent Development
10.7 Hikma Pharmaceuticals
10.7.1 Hikma Pharmaceuticals Company Information
10.7.2 Hikma Pharmaceuticals Introduction and Business Overview
10.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hikma Pharmaceuticals Amlodipine Besylate Products Offered
10.7.5 Hikma Pharmaceuticals Recent Development
10.8 Strides Pharma
10.8.1 Strides Pharma Company Information
10.8.2 Strides Pharma Introduction and Business Overview
10.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Strides Pharma Amlodipine Besylate Products Offered
10.8.5 Strides Pharma Recent Development
10.9 Upsher-Smith Laboratories
10.9.1 Upsher-Smith Laboratories Company Information
10.9.2 Upsher-Smith Laboratories Introduction and Business Overview
10.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Upsher-Smith Laboratories Amlodipine Besylate Products Offered
10.9.5 Upsher-Smith Laboratories Recent Development
10.10 InvaGen Pharmaceuticals
10.10.1 InvaGen Pharmaceuticals Company Information
10.10.2 InvaGen Pharmaceuticals Introduction and Business Overview
10.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Products Offered
10.10.5 InvaGen Pharmaceuticals Recent Development
10.11 Sun Pharmaceutical
10.11.1 Sun Pharmaceutical Company Information
10.11.2 Sun Pharmaceutical Introduction and Business Overview
10.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sun Pharmaceutical Amlodipine Besylate Products Offered
10.11.5 Sun Pharmaceutical Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Introduction and Business Overview
10.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Aurobindo Pharma Amlodipine Besylate Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Lupin Pharmaceuticals
10.13.1 Lupin Pharmaceuticals Company Information
10.13.2 Lupin Pharmaceuticals Introduction and Business Overview
10.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Lupin Pharmaceuticals Amlodipine Besylate Products Offered
10.13.5 Lupin Pharmaceuticals Recent Development
10.14 Zydus Pharmaceuticals
10.14.1 Zydus Pharmaceuticals Company Information
10.14.2 Zydus Pharmaceuticals Introduction and Business Overview
10.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Zydus Pharmaceuticals Amlodipine Besylate Products Offered
10.14.5 Zydus Pharmaceuticals Recent Development
10.15 Oxford Pharm
10.15.1 Oxford Pharm Company Information
10.15.2 Oxford Pharm Introduction and Business Overview
10.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Oxford Pharm Amlodipine Besylate Products Offered
10.15.5 Oxford Pharm Recent Development
10.16 Wockhardt
10.16.1 Wockhardt Company Information
10.16.2 Wockhardt Introduction and Business Overview
10.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Wockhardt Amlodipine Besylate Products Offered
10.16.5 Wockhardt Recent Development
10.17 Epic Pharma
10.17.1 Epic Pharma Company Information
10.17.2 Epic Pharma Introduction and Business Overview
10.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Epic Pharma Amlodipine Besylate Products Offered
10.17.5 Epic Pharma Recent Development
10.18 CR Pharmaceutical
10.18.1 CR Pharmaceutical Company Information
10.18.2 CR Pharmaceutical Introduction and Business Overview
10.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.18.4 CR Pharmaceutical Amlodipine Besylate Products Offered
10.18.5 CR Pharmaceutical Recent Development
10.19 Alkem Laboratories
10.19.1 Alkem Laboratories Company Information
10.19.2 Alkem Laboratories Introduction and Business Overview
10.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Alkem Laboratories Amlodipine Besylate Products Offered
10.19.5 Alkem Laboratories Recent Development
10.20 MACLEODS
10.20.1 MACLEODS Company Information
10.20.2 MACLEODS Introduction and Business Overview
10.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2018-2024)
10.20.4 MACLEODS Amlodipine Besylate Products Offered
10.20.5 MACLEODS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Amlodipine Besylate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Amlodipine Besylate Industrial Chain Analysis
11.4 Amlodipine Besylate Market Dynamics
11.4.1 Amlodipine Besylate Industry Trends
11.4.2 Amlodipine Besylate Market Drivers
11.4.3 Amlodipine Besylate Market Challenges
11.4.4 Amlodipine Besylate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Amlodipine Besylate Distributors
12.3 Amlodipine Besylate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 2.5mg Tablets
Table 2. Major Company of 5mg Tablets
Table 3. Major Company of 10mg Tablets
Table 4. Global Amlodipine Besylate Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 6. Global Amlodipine Besylate Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Amlodipine Besylate Sales by Type (2018-2024) & (US& Million)
Table 8. Global Amlodipine Besylate Market Share in Value by Type (2018-2024)
Table 9. Global Amlodipine Besylate Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 11. Global Amlodipine Besylate Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Amlodipine Besylate Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Amlodipine Besylate Sales Market Share in Value by Type (2024-2029)
Table 14. Global Amlodipine Besylate Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 16. North America Amlodipine Besylate Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Amlodipine Besylate Sales (K Units) by Type (2018-2024)
Table 18. Europe Amlodipine Besylate Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Amlodipine Besylate Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Amlodipine Besylate Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Amlodipine Besylate Sales (K Units) by Type (2018-2024)
Table 22. Latin America Amlodipine Besylate Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Amlodipine Besylate Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Amlodipine Besylate Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Amlodipine Besylate Sales by Company (2018-2024) & (K Units)
Table 26. Global Amlodipine Besylate Sales Share by Company (2018-2024)
Table 27. Global Amlodipine Besylate Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Amlodipine Besylate Revenue Share by Company (2018-2024)
Table 29. Global Market Amlodipine Besylate Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Amlodipine Besylate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Amlodipine Besylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2022)
Table 33. Date of Key Manufacturers Enter into Amlodipine Besylate Market
Table 34. Key Manufacturers Amlodipine Besylate Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Amlodipine Besylate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Amlodipine Besylate Sales by Region (2018-2024) & (K Units)
Table 38. Global Amlodipine Besylate Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Amlodipine Besylate Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Amlodipine Besylate Sales Market Share in Value by Region (2018-2024)
Table 41. Global Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 43. Global Amlodipine Besylate Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Amlodipine Besylate Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Amlodipine Besylate Sales Market Share in Value by Region (2024-2029)
Table 46. Global Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Amlodipine Besylate Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 49. Global Amlodipine Besylate Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Amlodipine Besylate Sales Market Share in Value by Application (2018-2024)
Table 52. Global Amlodipine Besylate Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 54. Global Amlodipine Besylate Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Amlodipine Besylate Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Amlodipine Besylate Sales Market Share in Value by Application (2024-2029)
Table 57. Global Amlodipine Besylate Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Amlodipine Besylate Sales by Application (2018-2024) (K Units)
Table 59. North America Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Amlodipine Besylate Sales by Application (2018-2024) (K Units)
Table 61. Europe Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Amlodipine Besylate Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Amlodipine Besylate Sales by Application (2018-2024) (K Units)
Table 65. Latin America Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Amlodipine Besylate Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Amlodipine Besylate Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 69. North America Amlodipine Besylate Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Amlodipine Besylate Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Amlodipine Besylate Sales Market Share in Value by Country (2018-2024)
Table 72. North America Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 73. North America Amlodipine Besylate Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Amlodipine Besylate Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Amlodipine Besylate Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 77. Europe Amlodipine Besylate Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Amlodipine Besylate Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Amlodipine Besylate Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 81. Europe Amlodipine Besylate Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Amlodipine Besylate Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Amlodipine Besylate Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Amlodipine Besylate Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Amlodipine Besylate Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Amlodipine Besylate Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Amlodipine Besylate Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Amlodipine Besylate Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Amlodipine Besylate Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Amlodipine Besylate Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Amlodipine Besylate Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Amlodipine Besylate Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Amlodipine Besylate Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Amlodipine Besylate Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Amlodipine Besylate Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Amlodipine Besylate Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Amlodipine Besylate Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Amlodipine Besylate Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Amlodipine Besylate Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Amlodipine Besylate Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Amlodipine Besylate Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Amlodipine Besylate Sales Market Share in Value by Country (2024-2029)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Amlodipine Besylate Product
Table 112. Pfizer Recent Development
Table 113. Mylan Company Information
Table 114. Mylan Introduction and Business Overview
Table 115. Mylan Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Mylan Amlodipine Besylate Product
Table 117. Mylan Recent Development
Table 118. Dr. Reddy's Laboratories Company Information
Table 119. Dr. Reddy's Laboratories Introduction and Business Overview
Table 120. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 122. Dr. Reddy's Laboratories Recent Development
Table 123. Apotex Company Information
Table 124. Apotex Introduction and Business Overview
Table 125. Apotex Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Apotex Amlodipine Besylate Product
Table 127. Apotex Recent Development
Table 128. Teva Pharmaceutical Company Information
Table 129. Teva Pharmaceutical Introduction and Business Overview
Table 130. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Teva Pharmaceutical Amlodipine Besylate Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Cipla Company Information
Table 134. Cipla Introduction and Business Overview
Table 135. Cipla Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Cipla Amlodipine Besylate Product
Table 137. Cipla Recent Development
Table 138. Hikma Pharmaceuticals Company Information
Table 139. Hikma Pharmaceuticals Introduction and Business Overview
Table 140. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 142. Hikma Pharmaceuticals Recent Development
Table 143. Strides Pharma Company Information
Table 144. Strides Pharma Introduction and Business Overview
Table 145. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Strides Pharma Amlodipine Besylate Product
Table 147. Strides Pharma Recent Development
Table 148. Upsher-Smith Laboratories Company Information
Table 149. Upsher-Smith Laboratories Introduction and Business Overview
Table 150. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 152. Upsher-Smith Laboratories Recent Development
Table 153. InvaGen Pharmaceuticals Company Information
Table 154. InvaGen Pharmaceuticals Introduction and Business Overview
Table 155. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 157. InvaGen Pharmaceuticals Recent Development
Table 158. Sun Pharmaceutical Company Information
Table 159. Sun Pharmaceutical Introduction and Business Overview
Table 160. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Sun Pharmaceutical Amlodipine Besylate Product
Table 162. Sun Pharmaceutical Recent Development
Table 163. Aurobindo Pharma Company Information
Table 164. Aurobindo Pharma Introduction and Business Overview
Table 165. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Aurobindo Pharma Amlodipine Besylate Product
Table 167. Aurobindo Pharma Recent Development
Table 168. Lupin Pharmaceuticals Company Information
Table 169. Lupin Pharmaceuticals Introduction and Business Overview
Table 170. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 172. Lupin Pharmaceuticals Recent Development
Table 173. Zydus Pharmaceuticals Company Information
Table 174. Zydus Pharmaceuticals Introduction and Business Overview
Table 175. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 177. Zydus Pharmaceuticals Recent Development
Table 178. Oxford Pharm Company Information
Table 179. Oxford Pharm Introduction and Business Overview
Table 180. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Oxford Pharm Amlodipine Besylate Product
Table 182. Oxford Pharm Recent Development
Table 183. Wockhardt Company Information
Table 184. Wockhardt Introduction and Business Overview
Table 185. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Wockhardt Amlodipine Besylate Product
Table 187. Wockhardt Recent Development
Table 188. Epic Pharma Company Information
Table 189. Epic Pharma Introduction and Business Overview
Table 190. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Epic Pharma Amlodipine Besylate Product
Table 192. Epic Pharma Recent Development
Table 193. CR Pharmaceutical Company Information
Table 194. CR Pharmaceutical Introduction and Business Overview
Table 195. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. CR Pharmaceutical Amlodipine Besylate Product
Table 197. CR Pharmaceutical Recent Development
Table 198. Alkem Laboratories Company Information
Table 199. Alkem Laboratories Introduction and Business Overview
Table 200. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Alkem Laboratories Amlodipine Besylate Product
Table 202. Alkem Laboratories Recent Development
Table 203. MACLEODS Company Information
Table 204. MACLEODS Introduction and Business Overview
Table 205. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. MACLEODS Amlodipine Besylate Product
Table 207. MACLEODS Recent Development
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Amlodipine Besylate Market Trends
Table 211. Amlodipine Besylate Market Drivers
Table 212. Amlodipine Besylate Market Challenges
Table 213. Amlodipine Besylate Market Restraints
Table 214. Amlodipine Besylate Distributors List
Table 215. Amlodipine Besylate Downstream Customers
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Amlodipine Besylate Product Picture
Figure 2. Global Amlodipine Besylate Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Amlodipine Besylate Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Amlodipine Besylate Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 2.5mg Tablets
Figure 6. Global 2.5mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 5mg Tablets
Figure 8. Global 5mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 10mg Tablets
Figure 10. Global 10mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Amlodipine Besylate Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Amlodipine Besylate Sales Market Share by Type in 2022 & 2029
Figure 13. North America Amlodipine Besylate Sales Market Share in Volume by Type in 2022
Figure 14. North America Amlodipine Besylate Sales Market Share in Value by Type in 2022
Figure 15. Europe Amlodipine Besylate Sales Market Share in Volume by Type in 2022
Figure 16. Europe Amlodipine Besylate Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Amlodipine Besylate Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Amlodipine Besylate Sales Market Share in Value by Type in 2022
Figure 19. Latin America Amlodipine Besylate Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Amlodipine Besylate Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Amlodipine Besylate Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Amlodipine Besylate Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Amlodipine Besylate Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Amlodipine Besylate Revenue in 2022
Figure 25. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of High Blood Pressure
Figure 27. Global High Blood Pressure Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Heart Disease
Figure 29. Global Heart Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Amlodipine Besylate Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Amlodipine Besylate Sales Market Share by Application in 2022 & 2029
Figure 32. North America Amlodipine Besylate Sales Market Share in Volume by Application in 2022
Figure 33. North America Amlodipine Besylate Sales Market Share in Value by Application in 2022
Figure 34. Europe Amlodipine Besylate Sales Market Share in Volume by Application in 2022
Figure 35. Europe Amlodipine Besylate Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Amlodipine Besylate Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Amlodipine Besylate Sales Market Share in Value by Application in 2022
Figure 38. Latin America Amlodipine Besylate Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Amlodipine Besylate Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Amlodipine Besylate Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Amlodipine Besylate Manufacturing Cost Structure
Figure 43. Amlodipine Besylate Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed